Coronary Artery Calcium Testing in Symptomatic Patients: An Issue of Diagnostic Efficiency [0.03%]
冠状动脉钙化检测在有症状患者中的诊断效率问题
Chad B McBride,Michael K Cheezum,Rosco S Gore et al.
Chad B McBride et al.
The detection and quantification of coronary artery calcification (CAC) significantly improves cardiovascular risk prediction in asymptomatic patients. Many have advocated for expanded CAC testing in symptomatic patients based on data demon...
Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases [0.03%]
用于脂蛋白及其相关疾病成像的纳米晶芯脂蛋白生物模拟物
Francois Fay,Brenda L Sanchez-Gaytan,David P Cormode et al.
Francois Fay et al.
Lipoproteins are natural nanoparticles composed of phospholipids and apolipoproteins that transport lipids throughout the body. As key effectors of lipid homeostasis, the functions of lipoproteins have been demonstrated to be crucial during...
Gary S Mak,Quynh A Truong
Gary S Mak
For patients with cardiac devices, cardiac computed tomography (CT) remains the mainstay for imaging due to its superior resolution as compared with echocardiography and nuclear studies and no contraindication to metal as with cardiac magne...
Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis [0.03%]
用于动脉粥样硬化血管壁磁共振成像(MRI)的钆基对比剂
Claudia Calcagno,Sarayu Ramachandran,Antoine Millon et al.
Claudia Calcagno et al.
Cardiovascular disease due to atherosclerosis is the number one killer in the Western world, and threatens to become the major cause of morbidity and mortality worldwide. It is therefore paramount to develop non-invasive methods for the det...
Beyond Coronary Stenosis: Coronary Computed Tomographic Angiography for the Assessment of Atherosclerotic Plaque Burden [0.03%]
超越冠状动脉狭窄：冠状计算机断层血管造影在评估动脉粥样硬化斑块中的应用
Alan C Kwan,George Cater,Jose Vargas et al.
Alan C Kwan et al.
Coronary computed tomographic angiography (CCTA) is emerging as a key non-invasive method for assessing cardiovascular risk by measurement of coronary stenosis and coronary artery calcium (CAC). New advancements in CCTA technology have led ...
David E Sosnovik,Peter Caravan
David E Sosnovik
Two new molecular MRI agents have been approved for clinical use within the last 3 years, and a third agent has completed phase-2 clinical trials. A wealth of preclinical data is also emerging on the general safety of many molecular MR imag...
Oxygenation and flow in the limbs: Novel methods to characterize peripheral artery disease [0.03%]
四肢氧合与血流：表征外周动脉疾病的新方法
David Lopez,Christopher M Kramer
David Lopez
Peripheral arterial disease (PAD) affects approximately 8 million Americans and is associated with high morbidity and increased mortality. Current therapies for PAD are limited and development of new therapeutic agents is needed. Present di...
Edward M Hsiao,Bilal Ali,Sharmila Dorbala
Edward M Hsiao
Recent technological advances have fueled the growth in hybrid radionuclide and CT imaging of the heart. Noninvasive imaging studies are reliable means to diagnose coronary artery disease (CAD), stratify risk, and guide clinical management....
Amy W Pollak,Christopher M Kramer
Amy W Pollak
Evaluation of peripheral arterial disease by cardiovascular magnetic resonance imaging continues to develop. Of the clinical diagnostics tests currently available, magnetic resonance angiography is well established as one of the preferred t...
Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography [0.03%]
化疗药物心脏毒性的评估：超声心动图的作用
Timothy C Tan,Marielle Scherrer-Crosbie
Timothy C Tan
Advancements in cancer treatment have resulted in sufficient survival length for patients to experience treatment-related cardiac complications. In particular, chemotherapy-induced cardiac dysfunction significantly impacts morbidity and mor...